CARRYL MV 0.3/500/60mg Tablet 10s

Unsafe: Avoid consuming alcohol with CARRYL MV 0.3MG/500MG/60MG TABLET as it is deemed unsafe.Unsafe: Avoid consuming alcohol with CARRYL MV 0.3MG/500MG/60MG TABLET as it is deemed unsafe.

CARRYL MV 0.3MG/500MG/60MG TABLET may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.CARRYL MV 0.3MG/500MG/60MG TABLET may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.

CARRYL MV 0.3MG/500MG/60MG TABLET should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.CARRYL MV 0.3MG/500MG/60MG TABLET should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.

Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.

CARRYL MV 0.3MG/500MG/60MG TABLET should be used with caution in patients with kidney disease. Dose adjustment of CARRYL MV 0.3MG/500MG/60MG TABLET may be needed. Doctor consultation is advised.Use of CARRYL MV 0.3MG/500MG/60MG TABLET is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.CARRYL MV 0.3MG/500MG/60MG TABLET should be used with caution in patients with kidney disease. Dose adjustment of CARRYL MV 0.3MG/500MG/60MG TABLET may be needed. Doctor consultation is advised.Use of CARRYL MV 0.3MG/500MG/60MG TABLET is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.

CARRYL MV 0.3MG/500MG/60MG TABLET should be used with caution in patients with liver disease. Dose adjustment of CARRYL MV 0.3MG/500MG/60MG TABLET may be needed. Doctor consultation is advised.CARRYL MV 0.3MG/500MG/60MG TABLET is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.CARRYL MV 0.3MG/500MG/60MG TABLET should be used with caution in patients with liver disease. Dose adjustment of CARRYL MV 0.3MG/500MG/60MG TABLET may be needed. Doctor consultation is advised.CARRYL MV 0.3MG/500MG/60MG TABLET is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.